Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Fish and Richardson
Deloitte
Teva
Federal Trade Commission
Argus Health
Daiichi Sankyo
Baxter

Generated: June 24, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nilotinib hydrochloride monohydrate

« Back to Dashboard

nilotinib hydrochloride monohydrate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0526-51
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0526-87
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0592-51
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0592-87
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Citi
Deloitte
Harvard Business School
Johnson and Johnson
Medtronic
Queensland Health
Merck